4//SEC Filing
Ashar Bhavesh 4
Accession 0001193125-25-304160
CIK 0001863127other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 6:17 PM ET
Size
5.3 KB
Accession
0001193125-25-304160
Insider Transaction Report
Form 4
Ashar Bhavesh
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-12-01+300,000→ 300,000 totalExercise: $20.81Exp: 2035-11-30→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on December 1, 2026, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
Related Parties
1- filerCIK 0001849740
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 6:17 PM ET
- Size
- 5.3 KB